Clinical Trial Results: Safety and Suitability of Supplementing Early MIP Surgery (MIPS) of ICH With Pioglitazone [Phase 2]

View source ↗

Summary

Phase 2 trial assessing safety and suitability of pioglitazone supplementation during early minimally invasive surgery for intracerebral hemorrhage.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Intracerebral Hemorrhage
• Intraventricular Hemorrhage

Drugs mentioned

• PIOGLITAZONE (Pioglitazone)

Snippet

Sponsor: University of Maryland, Baltimore | Conditions: Intracerebral Haemorrhage, Intraventricular | Phase 2 | Status: TERMINATED | Results posted: 2026-04-28